Related Experiment Videos

Late effects of adjuvant therapy for breast cancer

C L Shapiro¹, A Recht

¹Breast Evaluation Center, Dana-Farber Cancer Institute, Boston, Mass 02125.

Journal of the National Cancer Institute. Monographs

|January 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.

European journal of cancer care·2015

Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo.

Breast cancer research and treatment·2011

Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2011

Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.

European journal of cancer (Oxford, England : 1990)·2011

Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?

Breast cancer research and treatment·2008

See all related articles